These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

467 related items for PubMed ID: 8102826

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Sabin type 2 polioviruses with intertypic vaccine/vaccine recombinant genomes.
    Georgopoulou A, Markoulatos P.
    Eur J Clin Microbiol Infect Dis; 2001 Nov; 20(11):792-9. PubMed ID: 11783695
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Genomic modifications in naturally occurring neurovirulent revertants of Sabin 1 polioviruses.
    Otelea D, Guillot S, Furione M, Combiescu AA, Balanant J, Candrea A, Crainic R.
    Dev Biol Stand; 1993 Nov; 78():33-8. PubMed ID: 8099049
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Evolution of the Sabin type 1 poliovirus in humans: characterization of strains isolated from patients with vaccine-associated paralytic poliomyelitis.
    Georgescu MM, Balanant J, Macadam A, Otelea D, Combiescu M, Combiescu AA, Crainic R, Delpeyroux F.
    J Virol; 1997 Oct; 71(10):7758-68. PubMed ID: 9311861
    [Abstract] [Full Text] [Related]

  • 7. Type 2 poliovirus recombinants isolated from vaccine-associated cases and from healthy contacts in Brazil.
    Friedrich F, Da-Silva EF, Schatzmayr HG.
    Acta Virol; 1996 Feb; 40(1):27-33. PubMed ID: 8886095
    [Abstract] [Full Text] [Related]

  • 8. A Cluster of Paralytic Poliomyelitis Cases Due to Transmission of Slightly Diverged Sabin 2 Vaccine Poliovirus.
    Korotkova EA, Gmyl AP, Yakovenko ML, Ivanova OE, Eremeeva TP, Kozlovskaya LI, Shakaryan AK, Lipskaya GY, Parshina IL, Loginovskikh NV, Morozova NS, Agol VI.
    J Virol; 2016 Jul 01; 90(13):5978-88. PubMed ID: 27099315
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Use of mutational pattern in 5'-NCR and VP1 regions of polioviruses for molecular diagnosis.
    Pliaka V, Dedepsidis E, Kyriakopoulou Z, Papadopoulou I, Levidiotou S, Markoulatos P.
    Mol Cell Probes; 2007 Aug 01; 21(4):267-75. PubMed ID: 17336496
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The natural genomic variability of poliovirus analyzed by a restriction fragment length polymorphism assay.
    Balanant J, Guillot S, Candrea A, Delpeyroux F, Crainic R.
    Virology; 1991 Oct 01; 184(2):645-54. PubMed ID: 1679577
    [Abstract] [Full Text] [Related]

  • 15. Genetic recombination in wild-type poliovirus.
    Dahourou G, Guillot S, Le Gall O, Crainic R.
    J Gen Virol; 2002 Dec 01; 83(Pt 12):3103-3110. PubMed ID: 12466487
    [Abstract] [Full Text] [Related]

  • 16. Evolution of a rare vaccine-derived multirecombinant poliovirus.
    Karakasiliotis I, Paximadi E, Markoulatos P.
    J Gen Virol; 2005 Nov 01; 86(Pt 11):3137-3142. PubMed ID: 16227237
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Site analysis of recombinant and mutant poliovirus isolates of Sabin origin from patients and from vaccinees.
    Karakasiliotis I, Markoulatos P, Katsorchis T.
    Mol Cell Probes; 2004 Apr 01; 18(2):103-9. PubMed ID: 15051119
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.